
Michael Schulder MD
Brain & Spinal Tumor, Pituitary Surgery, Skull Base, Stereotactic & Functional Neurosurgery
Professor, Neurosurgery, Zucker School of Medicine at Hofstra/Northwell
Join to View Full Profile
450 Lakeville RoadLake Success, NY 11042
Phone+1 516-941-1260
Fax+1 516-941-1272
Dr. Schulder is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Michael Schulder is a neurosurgeon based in Manhasset, NY, with expertise in brain and spinal tumors, skull base, and stereotactic and functional neurosurgery. He is the Director of the Brain Tumor Center at the Northwell Neuroscience Institute, Professor of Neurosurgery at the Zucker School of Medicine at Hofstra/Northwell, Vice Chair and Residency Program Director in the Northwell Department of Neurosurgery, and Co-Director of the Northwell Stereotactic Radiosurgery Center. He completed his residency in neurological surgery at Montefiore Medical Center/Albert Einstein College of Medicine. Dr. Schulder is experienced in deep brain stimulation, neurosurgical oncology, stereotactic radiosurgery, and skull base surgery. He has contributed to the field through various publications in prestigious journals such as Nature, Neurosurgery, and the Journal of Neurosurgery. Dr. Schulder has served as a principal investigator in multiple clinical trials, notably focusing on new advances in brain tumor treatment. Throughout his career, he has been recognized with multiple honors including from Rutgers New Jersey Medical School, the Zucker School of Medicine at Hofstra/Northwell, and the World Society for Stereotactic and Functional Neurosurgery.
Education & Training
Montefiore Medical Center/Albert Einstein College of MedicineResidency, Neurological Surgery, 1983 - 1988
Jacobi Medical CenterInternship, Transitional Year, 1982 - 1983
Columbia University Vagelos College of Physicians and SurgeonsClass of 1982
Certifications & Licensure
NJ State Medical License 1988 - 2027
NY State Medical License 1983 - 2027
American Board of Neurological Surgery Neurological Surgery
Awards, Honors, & Recognition
- Top Doctors: New York Metro Area Castle Connolly, 2015-2024
- Newsday - Top Doctors on Long Island Castle Connolly, 2010-2024
- CMS Meaningful Use Stage 1 Certification Allscripts TouchWorks EHR (Complete), Allscripts, 2015-2017
Clinical Trials
- Magnetic Resonance Imaging-Guided Laser Induced Thermal Therapy for Treatment of Metastatic Brain Tumors Start of enrollment: 2008 Sep 01
- Safety and Efficacy Study of SL-701, a Glioma-Associated Antigen Vaccine To Treat Recurrent Glioblastoma Multiforme
- A Study of Selinexor in Combination With Standard of Care Therapy for Newly Diagnosed or Recurrent Glioblastoma Start of enrollment: 2020 Jun 08
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- Phase 1 dose-escalation trial combining sulfasalazine and stereotactic radiosurgery in patients with recurrent glioblastoma.Bente Sandvei Skeie, Alexander Richard Craig-Craven, Eli Renate Grüner, Martin Biermann, Frank Riemer
Redox Biology. 2026-05-30 - Active surveillance versus stereotactic radiosurgery for Koos grade I and II vestibular schwannoma in patients aged 60 years or older.Mariam Ishaque, Georgios Mantziaris, Salem M Tos, Bardia Hajikarimloo, Angelica M Fuentes
Journal of Neurosurgery. 2026-05-15 - Comparison of neuropsychological side effects between contemporary radiofrequency ablative neurosurgery for psychiatric disorders and conventional neurosurgical proced...Osvaldo Vilela-Filho, Matheus A Bannach, Adriano M Lino-Filho, Clement Hamani, Bart Nuttin
Journal of Neurology, Neurosurgery, and Psychiatry. 2026-05-14
Authored Content
- American Views of Sir Victor Horsley in the Era of CushingMarch 2018
Press Mentions
TRK Inhibitor Active in Treatment-Refractory GlioblastomaNovember 27th, 2024
Northwest Biotherapeutics: Data Is Done, Just Wait for ApprovalNovember 23rd, 2022
Alpheus Medical Treats First Patients in First-in-Human Clinical Trial for Novel High-Grade Glioma Brain Cancer TreatmentNovember 10th, 2022
Professional Memberships
- Fellow
- Member
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









